°ê¥Á°·±d§½ ¿ò¶Ç¯e¯f½u¤W¿Ô¸ß°Ï¡GG6pD Q&A-¤@¯ë¥Á²³ | 2007-03-29 | Page:1/1 |
G6pD Q&A-¤@¯ë¥Á²³ Glucose-6-Phosphate Dehydrogenase Deficiency; G6PD Deficiency Glucose-6-Phosphate Dehydrogenase Deficiencey(G6PD) ¸²µå¿}¤»ÁC»ÄÆQ¥h²B»Ã¯À¯Ê¥F¯g Åú¨§¯g ¦ó¿×Åú¨§¯g¡H Åú¨§¯g¬O¤@ºØ«Ü±`¨£ªºX¬V¦âÅé©ÊÁp¿ò¶Çªº¥ý¤Ñ¥NÁ²§±`¯e¯f¡C¸²µå¿}-¤»-ÁC»ÄÆQ¥h²B»Ã¯À(Glucose-6-phosphate dehydrogenase,G6PD)¬°¬õ¦å²y¤À¸Ñ¸²µå¿}¥NÁ¹Lµ{¤¤¤@«n»Ã¯À¡C¥¦¦b¤HÅ餺¨ó§U¸²µå¿}¶i¦æ·s³¯¥NÁ¡A¦¹¹Lµ{¤¤²£¥Í¤@ºØ«OÅ@¬õ¦å²yªºª«½è¡A¥H¹ï§Ü¬Y¨Ç¯S§Oªº®ñ¤Æª«¡A¦¹¯g±wªÌ¦]¯Ê¥F³oºØ»Ã¯À¡A¨Ï¬õ¦å²y®e©ö¨ü¨ì¬Y¨Ç¯S©wª«½èªº¯}Ãa¦Óµo¥Í·»¦å¡A¨Ò¦p±µÄ²¨ì®ñ¤Æ©ÊÃĪ«¡BÅú¨§¡B¼Ì¸£¤Y(¯ä¤Y)¡BµµÃĤô¡BÁDÓi¾¯¡A¥H¤Î³¡¥÷¸Ñ¼öÂíµh¾¯®É¡AYµ{«×ÄY«§Yµo¥Í«æ©Ê·»¦å©Ê³h¦å¡C ½Ð°ÝÅú¨§¯g±wªÌ¥i¥HÀ¿³ßÀø§´¶Ü¡H ¤é±`¥Í¬¡ùØ¡AÅú¨§¯g¯f¤Hnª`·N´X¥ó¨Æ¡A¥]¬AÁקK¦YÅú¨§¡A¦çÂd¤Î´Z©Òùؤ£¥i¥H¨Ï¥Î¼Ì¸£¤Y¡A¨ü¶Ë®É¤£n¨Ï¥Î§tÀsÁxµµªº®ø¬r¤ô¡A¨Ò¦pµµÃĤôµ¥¡C¨Ã¥BÁקK¨Ï¥Î¤U¦CÃÄ«~¡G ¤@¡B§ÜºÄ¯eÃĪ«¡A¨Ò¦p primaquine¡Bpamaquine¡Bpentaquine¡Bplasmoquine¡C¤G¡B§Ü·P¬VÃĪ«¤¤ªºÁDÓiÃÄ¡A¨Ò¦p sulfanilamide¡Bsulfapyridine¡Bsulfisoxazole¡Bsulfacetamide¡Bsalicylazosulfapyridine¡Bsulfamethoxypyridazine¡C ¤T¡B¸Ñ¼ö¤îµh¾¯¡A¨Ò¦p aspirin¡Bacetanilide¡Bphenacetin¡Bantipyrine¡Baminopyrine¡Ap-aminosalicylic acid¡C ¥|¡B¬Y¨Ç§Ü·P¬V©Î®ø¬r¾¯¡A¨Ò¦p nitrofurantoin¡Bfurazolidone¡Bfuraltadone¡C ¤¡B¨ä¥L¤Æ¾Ç«~¡A¨Ò¦p²þ¡]naphthalene¡^¡AÀsÁxµµ¡A¥Ò°òÂÅ¡]methylene blue¡^¡Bphenylhydrazine¡Bacetylphenylhydrazine¡Bprobenecid¡]°§¿»Ä¾¯¡^¡Bsulfoxonoe¡C ³ßÀø§´À³¸Ó¬O¥i¥H¨Ï¥Îªº¡C Åú¨§¯g¬O§_¤£¯à¦Y¶À½¬¡B³½ªo¡H ®a¶À½¬(coptis teeta),¬O¯óÃĪº¤@ºØ¦¨¤À¡A¦³§ÜºÄ¯eªº®ÄªG¡A¦p¦P¨ä¥L§ÜºÄ¯eÃĪ«¡A¥i¯à·|³y¦¨Åú¨§¯g±wªÌªº·»¦å¡C³½ªoÄÝ©ó¯×ªÕ¡AÀ³¹ïÅú¨§¯g±wªÌ¨S¦³¼vÅT¡C Y¬OÁʶR¼Ì¾ð©Ò»s³yªº³ÃÑ(¨Ò¦pÀ\®à¡B§É²Õµ¥¼Ì¾ð³ÃÑ¡A¦³ªº·|¦³¼Ì¾ðªº¨ý¹D)¡A¬O§_¹ï¦³Åú¨§¯gªº¤p«Ä¦³¼vÅT¡H¼Ì¾ðªº¨ý¹D¬O¤£¬O¹³¼Ì¸£¤Y¤@¼Ë·|¹ïÅú¨§¯gªº¤H³y¦¨¼vÅT¡H «UºÙªº¼Ì¸£¤Y¡A¨Ã«D¼Ì¾ð¤¤´£·Ò¥X¨Óªº¤ÑµMª«½è¡A¥Ø«e¥xÆW¤j³¡¤Àªº¼Ì¸£¤Y¬O¤Æ¾Ç¦X¦¨¡A§t¤@ºØ¤Æ¾Ç¦¨¤À¡A¾Ç¦W¥sNaphthalene¡A¤~¬OP¯fªº¥D¦]¡A©Ò¥H¤@¯ëªº¤ÑµM¼Ì¾ð»s«~À³¸Ó¤£·|¼vÅT¡A¼Ì¾ð©Ò»s³yªº³ÃѨ䣷|¹ïÅú¨§¯gªº¤H³y¦¨¼vÅT¡C ®a±Ú¤º¦³Åú¨§¯gªº¤p«Ä¡A¥H«á¤p«Ä¬O§_«Ü¦³¥i¯à¤]·|¦³Åú¨§¯g¡H ®a±Ú¤º¦³Åú¨§¯gªº¤p«Ä¡A¥H«á¥Í¤U¤p«Ä¦³Åú¨§¯gªº¾÷²v¥i¯à¤ñ¥¿±`¤H°ª¤@¨Ç¡C Åú¨§¨à¥i¥H¦Y¯»¥ú©Î¥VÂήL¯óµ¥¶}G¤¤ÃĶܡH ¥Ø«e¤âÃä¨ÃµL¸ê®ÆÅã¥ÜÅú¨§¨à¥i¥H©Î¤£¥i¥H¦Y¯»¥ú©Î¥VÂήL¯óµ¥¶}G¤¤ÃÄ¡A¦ý¤¤ÃĦ¨¤À½ÆÂø¡A¥B¦³¥i¯à§t¦³¬r¤§«ª÷ÄÝ¡A¨Ã¤£¤Ó¾A¦XÀ¦¨à¹¥Î¡C ¤p«Ä¦³Åú¨§¯g¡A ½Ð°Ý¸Óª`·N¨Ç¤°»ò¡H ¤p«Ä¦³Åú¨§¯gÀ³¸Óª`·N¡G ¤@¡B¤£ÀH·NªAÃÄ¡A©Ò¦³ÃĪ«§¡»Ý¸g¥ÑÂå®v³B¤è¡C¤G¡BÁקK¦YÅú¨§¡C¤T¡B¦çÃo»P´Z©Ò¤£¥i¥H©ñ¸m²þ¤Y(¯ä¤Y)¡C¥|¡B¤£¨Ï¥ÎÀsÁxµµ(µµÃĤô)¡C¤¡B¦pªGµo²{±w«Ä¦³¶À¯n¡BÁy¦â»a¥Õ¡B³h¦å©Î¯ù¦â§¿ªº²{¶H®É¡AÀ³¾¨³t±a©¹Âå°|¶Eªv¡C¤»¡B.ÀH¨Äâ±aG6PD³Æ§Ñ¥d¥H¤è«K´NÂå®É§iª¾Âå®v¡C²{¥i¸g¥Ñ·s¥Í¨à¿zÀË´£¦°»´ú¥X·s¥Í¨à¬O§_¦³G6PD¯Ê¥F¯g¡C¦b·s¥Í¨à®É´Án¤p¤ß¥X²{¹L°ªªº¶À¯n¡A¨Ã¥BÁקK±µÄ²¤Wz¦³®`ª«½è¡A¦p¦¹«K¥i¥H¸ò¤@¯ë¤H¤@¼Ë°·±d¦a¥Í¬¡¡C ¦³Åú¨§¯g¤£ª¾¹D¥i¥H¾iÃdª«¡H¨Ò¦p¨ß¤l¡B¦Ñ¹«¡B¿ß©Îª¯¡C Åú¨§¯g±wªÌ¥i¥H¾iÃdª«¡C ¦³Åú¨§¯gªº¤H¥i¥H®½¦å¶Ü¡H ì«h¤WÅú¨§¯gªº¤H¥i¥H®½¦å¡C Åú¨§¨à¥i¥H¥Î»Tªo©Î¤@¯ëªº¨¾°A²G¶Ü¡H Áö¥¼´¿Å¥»¡Åú¨§¨à¥Î»Tªo©Î¤@¯ëªº¨¾°A²G¦Óµo¯f¡AµM¦Ó¦]¬°µLªk½T©w¥¦Ìªº½T¹ê¦¨¤À¬O§_§¹¥þ¦p¼Ð¥Ü©Ò¼gªº¡A¦]¦¹ÁÙ¬O«Øij±z¼f·V¬°¤§¡C §Úªº¤p«Ä¦³Åú¨§¯g¡A¦]¬°¨{¤lº¦®ð¡A¤£ª¾¥i¥HÀ¿¨º¤@ºØÃÄ»I¤~¦n¡H Åú¨§¯g¯f¤HÀ³¸ÓÁקK¨Ï¥Î¤U¦CÃÄ«~¡G ¤@¡B§ÜºÄ¯eÃĪ«¡A¨Ò¦p primaquine¡Bpamaquine¡Bpentaquine¡Bplasmoquine¡C¤G¡B§Ü·P¬VÃĪ«¤¤ªºÁDÓiÃÄ¡A¨Ò¦p sulfanilamide¡Bsulfapyridine¡Bsulfisoxazole¡Bsulfacetamide¡Bsalicylazosulfapyridine¡Bsulfamethoxypyridazine¡C ¤T¡B¸Ñ¼ö¤îµh¾¯¡A¨Ò¦p aspirin¡Bacetanilide¡Bphenacetin¡Bantipyrine¡Baminopyrine¡Ap-aminosalicylic acid¡C ¥|¡B¬Y¨Ç§Ü·P¬V©Î®ø¬r¾¯¡A¨Ò¦p nitrofurantoin¡Bfurazolidone¡Bfuraltadone¡C ¤¡B¨ä¥L¤Æ¾Ç«~¡A¨Ò¦p²þ¡]naphthalene¡^¡AÀsÁxµµ¡A¥Ò°òÂÅ¡]methylene blue¡^¡Bphenylhydrazine¡Bacetylphenylhydrazine¡Bprobenecid¡]°§¿»Ä¾¯¡^¡Bsulfoxonoe¡C ¦pªGÃÄ»I¤£§t¥H¤W¦¨¥÷¥H¤Î¼Ì¸£ªoÀ³¬O¤ñ¸û¦w¥þªº¡C Åú¨§¨à¥i¥H¥´¬y·P¬Ì]¶Ü¡H Åú¨§¨à¥i¥H¥´¬y·P¬Ì]¡A¥unº¡6Ó¤ë¤j¡A¨S¦³¹ï³J¥Õ©Î¬Ì]¹L±Óªº¯f¥v¡A¤]¨S¦³«æ©Ê¯e¯f©Îµo¿N§Y¥i¡C Åú¨§¯gªº±wªÌ¨ä¦å²G¤¤"¤@©w¨S¦³"G6PD¶Ü¡HÁÙ¬O¦å²G¤¤"¦³"G6PD¡A¥u¬OG6PD¤ñ¸û¤Ö©O? ³oÓ¯e¯f¾É¦]©óG6PDªº¯Ê¥F¡A¦å²G¤¤¦³G6PD¡A¥u¬OG6PD¤£¨¬¡A¥~¨Óªº®ñ¤Æ¨ë¿E·|³y¦¨¬õ¦å²y·»¦å¡C
|